We strive to provide excellent care in a warm and compassionate environment
Millar JK, James R, Christie S, Porteous DJ
In the semaglutide group, 569 out of 8803 patients (6.5%) experienced a primary cardiovascular end-point event, compared to 701 out of 8801 patients (8.0%) in the placebo group (hazard ratio, 0.80
Helps Prevent Cognitive Decline in Older Adults Higher circulating concentrations of IGF-1 in older adults may help prevent neuronal loss and age-related decline in cognitive functions
From regulatory strategy and FDA readiness to USP-aligned audits and safety monitoring, our experts ensure you stay compliant, efficient, and patient-focused.
However, when GLP-1 agonists are discontinued, so too are the drug benefits